Discover the detailed record of transactions filed by Anders Ullman, Membre du Conseil. Insider active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 2 reports have been published. History available since 16 July 2025. The latest transaction was disclosed on 18 July 2025 (Purchase). Regulator: FIN-FSA. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Anders Ullman is a board member of Swedish Orphan Biovitrum AB (publ). In this role, he participates in strategic decisions and oversees the company's operations. His expertise contributes to the direction and management of activities, ensuring that the company meets its objectives. He plays an active role in developing strategies to support Swedish Orphan Biovitrum's growth.